Breaking News

Yesterday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ABBV

AbbVie

$96.22

-0.42 (-0.43%)

, MYL

Mylan

$36.40

-0.17 (-0.46%)

08:06
07/17/18
07/17
08:06
07/17/18
08:06
Hot Stocks
AbbVie announces HUMIRA patent license with Mylan »

AbbVie (ABBV) announced…

ABBV

AbbVie

$96.22

-0.42 (-0.43%)

MYL

Mylan

$36.40

-0.17 (-0.46%)

AMGN

Amgen

$194.89

-1.01 (-0.52%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 27

    Jul

  • 08

    Aug

  • 10

    Sep

  • 13

    Nov

Monday
TEVA

Teva

$23.29

-0.45 (-1.90%)

07:01
07/16/18
07/16
07:01
07/16/18
07:01
Recommendations
Teva analyst commentary at Cantor Fitzgerald »

Teva price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 16

    Sep

NBIX

Neurocrine

$102.95

0.17 (0.17%)

, TEVA

Teva

$23.29

-0.45 (-1.90%)

06:51
07/16/18
07/16
06:51
07/16/18
06:51
Recommendations
Neurocrine, Teva analyst commentary at JPMorgan »

Neurocrine price target…

NBIX

Neurocrine

$102.95

0.17 (0.17%)

TEVA

Teva

$23.29

-0.45 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

  • 10

    Sep

  • 16

    Sep

Friday
TEVA

Teva

$23.29

-0.45 (-1.90%)

, NVS

Novartis

$78.78

-0.15 (-0.19%)

17:47
07/13/18
07/13
17:47
07/13/18
17:47
Hot Stocks
FDA announces voluntary recall of several medicines containing valsartan »

The U.S. Food and Drug…

TEVA

Teva

$23.29

-0.45 (-1.90%)

NVS

Novartis

$78.78

-0.15 (-0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 16

    Sep

AKRX

Akorn

$18.13

-1.11 (-5.77%)

, FSNUY

Fresenius SE

$0.00

(0.00%)

15:17
07/13/18
07/13
15:17
07/13/18
15:17
Hot Stocks
Akorn drops 8% on fifth day of buyout fight trial »

Shares of Akorn (AKRX)…

AKRX

Akorn

$18.13

-1.11 (-5.77%)

FSNUY

Fresenius SE

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MYL

Mylan

$36.63

0.41 (1.13%)

, BAYRY

Bayer

$0.00

(0.00%)

14:28
07/13/18
07/13
14:28
07/13/18
14:28
Periodicals
Breaking Periodicals news story on Mylan, Bayer »

Mylan loses challenge to…

MYL

Mylan

$36.63

0.41 (1.13%)

BAYRY

Bayer

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

VRX

Valeant

$23.55

-0.69 (-2.85%)

, TEVA

Teva

$23.30

-0.44 (-1.85%)

12:08
07/13/18
07/13
12:08
07/13/18
12:08
Recommendations
Valeant, Teva analyst commentary at Evercore ISI »

Evercore says FDA…

VRX

Valeant

$23.55

-0.69 (-2.85%)

TEVA

Teva

$23.30

-0.44 (-1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 10

    Sep

  • 16

    Sep

Thursday
NVS

Novartis

$78.82

1.67 (2.16%)

, TEVA

Teva

$23.80

0.04 (0.17%)

10:22
07/12/18
07/12
10:22
07/12/18
10:22
Hot Stocks
Novartis prevails in Gilenya patent challenge brought by Teva and Apotex »

The U.S. Patent and…

NVS

Novartis

$78.82

1.67 (2.16%)

TEVA

Teva

$23.80

0.04 (0.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Sep

  • 16

    Sep

AMGN

Amgen

$194.23

-1.43 (-0.73%)

, MYL

Mylan

$36.16

-0.52 (-1.42%)

07:50
07/12/18
07/12
07:50
07/12/18
07:50
Recommendations
Amgen, Mylan analyst commentary at Jefferies »

Mlyan priced Amgen…

AMGN

Amgen

$194.23

-1.43 (-0.73%)

MYL

Mylan

$36.16

-0.52 (-1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 13

    Nov

GLMD

Galmed

$12.68

1.69 (15.38%)

, AGN

Allergan

$174.42

-1.53 (-0.87%)

07:04
07/12/18
07/12
07:04
07/12/18
07:04
Initiation
Cantor puts $59 price target on 'undervalued' NASH play Galmed »

Cantor Fitzgerald analyst…

GLMD

Galmed

$12.68

1.69 (15.38%)

AGN

Allergan

$174.42

-1.53 (-0.87%)

MDGL

Madrigal Pharmaceuticals

$295.00

3.4 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.